Cargando…
Targeting CD147 for T to NK Lineage Reprogramming and Tumor Therapy
CD147 is highly expressed on the surface of numerous tumor cells to promote invasion and metastasis. Targeting these cells with CD147-specific antibodies has been validated as an effective approach for lung and liver cancer therapy. In the immune system, CD147 is recognized as a co-stimulatory recep...
Autores principales: | Geng, Jie-Jie, Tang, Juan, Yang, Xiang-min, Chen, Ruo, Zhang, Yang, Zhang, Kui, Miao, Jin-Lin, Chen, Zhi-Nan, Zhu, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478251/ https://www.ncbi.nlm.nih.gov/pubmed/28571672 http://dx.doi.org/10.1016/j.ebiom.2017.05.022 |
Ejemplares similares
-
CD147 deficiency in T cells prevents thymic involution by inhibiting the EMT process in TECs in the presence of TGFβ
por: Chen, Ruo, et al.
Publicado: (2020) -
CD98-induced CD147 signaling stabilizes the Foxp3 protein to maintain tissue homeostasis
por: Geng, JieJie, et al.
Publicado: (2021) -
CD147 blockade as a potential and novel treatment of graft rejection
por: Luan, Jing, et al.
Publicado: (2017) -
Chimeric antigen receptor T cells targeting CD147 for non-small cell lung cancer therapy
por: Chen, Xiao-Hong, et al.
Publicado: (2021) -
CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells
por: Wang, Ke, et al.
Publicado: (2020)